Dominic Borie
Director Técnico/Científico/I+D en KYVERNA THERAPEUTICS, INC. .
Fortuna: 6 M $ al 31/05/2024
Perfil
Dominic Borie is currently the President-Research & Development at Kyverna Therapeutics, Inc. He previously worked as an Executive Director at Allogene Therapeutics, Inc., a Medical Director at Amgen, Inc., a Senior Medical Director at Genentech, Inc., and a VP, Head-External Research & Development at Horizon Therapeutics Plc.
Dr. Borie also served as the Director-Transplantation Immunology Laboratory at Stanford University.
He holds a doctorate degree from The University of Texas at Austin and an undergraduate degree from North Carolina State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 07/02/2024 | 449 210 ( 1.04% ) | 6 M $ | 31/05/2024 |
Cargos activos de Dominic Borie
| Empresas | Cargo | Inicio |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 13/10/2022 |
Antiguos cargos conocidos de Dominic Borie.
| Empresas | Cargo | Fin |
|---|---|---|
| Stanford University | Corporate Officer/Principal | - |
| AMGEN INC. | Director Técnico/Científico/I+D | - |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| ALLOGENE THERAPEUTICS, INC. | Director/Miembro de la Junta | - |
Formación de Dominic Borie.
| The University of Texas at Austin | Doctorate Degree |
| North Carolina State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| KYVERNA THERAPEUTICS, INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Dominic Borie
